Home / CHD7 Knockout Cell Lines

CHD7 Knockout Cell Lines

Gene: CHD7

Official Full Name: chromodomain helicase DNA binding protein 7provided by HGNC

Gene Summary: This gene encodes a protein that contains several helicase family domains. Mutations in this gene have been found in some patients with the CHARGE syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO20410 CHD7 Knockout cell line (HeLa) Human CHD7 1:3~1:6 Negative Online Inquiry
KO20411 CHD7 Knockout cell line (HCT 116) Human CHD7 1:2~1:4 Negative Online Inquiry
KO20412 CHD7 Knockout cell line (HEK293) Human CHD7 1:3~1:6 Negative Online Inquiry
KO20413 CHD7 Knockout cell line (A549) Human CHD7 1:3~1:4 Negative Online Inquiry

Background

CHD7 Gene Knockout Cell Lines are advanced biological tools designed specifically for the functional study of the CHD7 gene, which is critically involved in various cellular processes, including development and differentiation. These engineered cell lines provide researchers with a precise model for investigating the role of CHD7 in various biological contexts, particularly its implications in genetic disorders such as CHARGE syndrome.

The primary function of these knockout cell lines is to allow for comprehensive examinations of CHD7's involvement in chromatin remodeling and gene regulation. By utilizing CRISPR/Cas9 technology to create targeted disruptions in the CHD7 gene, researchers can elucidate the downstream effects of CHD7 loss, enabling them to study phenotypic changes linked to aberrant cellular pathways. The cell lines are rigorously validated to ensure the absence of CHD7 expression, thereby providing a reliable model for functional assays, drug screening, and pathway analysis.

In a research environment, the importance of using CHD7 Gene Knockout Cell Lines lies in their potential application for understanding the molecular mechanisms underlying developmental anomalies associated with CHD7 mutations. Clinically, they represent valuable assets for the development of targeted therapies by facilitating the validation of therapeutic candidates that may restore normal cellular function in CHD7-related conditions.

Compared to traditional cell lines, which may carry variable expression of the CHD7 gene, these knockout models offer specificity and reproducibility, ensuring that findings are directly attributable to the loss of CHD7 function. Moreover, these lines can be readily utilized in high-throughput screening assays, fostering advancements in drug discovery and personalized medicine.

For researchers and clinicians keen on unraveling the complexities of gene function and its associated pathologies, CHD7 Gene Knockout Cell Lines present an indispensable resource. With our firm commitment to providing high-quality biological products, our expertise ensures that each cell line is produced under stringent conditions, delivering consistency and reliability for your innovative research pursuits.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.